DeepMed Research

Erasmus University Medical Center

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease

Phase 4

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Amiloride
Other: Low-sodium diet
Drug: Hydrochlorothiazide

First Posted Date: 2016-08-23

Last Posted Date: 2018-04-20

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 28

Registration Number: NCT02875886

Locations: 🇳🇱
ErasmusMC, Rotterdam, Netherlands

Magnetic Resonance Flow Measurements of Mesenteric Arteries and Veins and Portal Vein

Not Applicable

Conditions: Ischemia
Oxygen Deficiency

Interventions: Other: Nutri Drink

First Posted Date: 2016-08-23

Last Posted Date: 2021-03-09

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 62

Registration Number: NCT02875600

Locations: 🇳🇱
Erasmusmc, Rotterdam, Zuid Holland, Netherlands

The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis

Not Applicable

Completed

Conditions: Atopic Dermatitis

Interventions: Other: Placebo
Device: Staphefekt SA.100

First Posted Date: 2016-07-21

Last Posted Date: 2018-02-23

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 100

Registration Number: NCT02840955

Locations: 🇳🇱
Erasmus Medical Centre, Rotterdam, Netherlands

Dynamic Stress Perfusion CT for Detection of Inducible Myocardial Ischemia

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2016-06-23

Last Posted Date: 2020-12-11

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 180

Registration Number: NCT02810795

Locations: 🇳🇱
ErasmusMC, Rotterdam, Zuid Holland, Netherlands

Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry

Completed

Conditions: Coronary Heart Disease
Coronary Artery Disease

First Posted Date: 2016-06-20

Last Posted Date: 2017-01-04

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 352

Registration Number: NCT02805621

Locations: 🇳🇱
ErasmusMC, Rotterdam, Zuid Holland, Netherlands

Antibodies Causing Epilepsy Syndromes: The ACES Study.

Completed

Conditions: Auto-immune Encephalitis
Epilepsy

Interventions: Biological: vena punction

First Posted Date: 2016-06-16

Last Posted Date: 2022-07-28

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 582

Registration Number: NCT02802475

Locations: 🇳🇱
St. Elisabeth Hospital, Tilburg, Netherlands
🇳🇱
Academic Hospital Maastricht, Maastricht, Netherlands
🇳🇱
Erasmus Medisch Centrum, Rotterdam, Netherlands

and more 5 locations

RISAS Procedure in Node Positive Breast Cancer Following NAC

Not Applicable

Completed

Conditions: Breast Neoplasm
Axillary Lymph Nodes
Pathological Complete Response
Neoadjuvant Therapy

Interventions: Procedure: RISAS

First Posted Date: 2016-06-15

Last Posted Date: 2022-02-10

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 248

Registration Number: NCT02800317

Locations: 🇳🇱
Wilhelmina Hospital, Assen, Netherlands
🇳🇱
Amphia Hospital, Breda, Netherlands
🇳🇱
Albert Schweitzer Hospital, Dordrecht, Netherlands

and more 11 locations

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

Phase 4

Completed

Conditions: Colorectal Neoplasms
Gastrointestinal Stromal Tumors

Interventions: Drug: Esomeprazole 40mg concomitantly
Drug: Esomeprazole 40mg before
Drug: Regorafenib 160mg or 120mg

First Posted Date: 2016-06-15

Last Posted Date: 2018-08-02

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 31

Registration Number: NCT02800330

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, South Holland, Netherlands

Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol

Phase 3

Conditions: Cervical Intraepithelial Neoplasia

Interventions: Procedure: LLETZ
Drug: Imiquimod

First Posted Date: 2016-02-01

Last Posted Date: 2018-02-06

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 433

Registration Number: NCT02669459

Locations: 🇳🇱
Erasmus Medical center, Rotterdam, Zuid-Holland, Netherlands

Pasireotide LAR and Pegvisomant Study in Acromegaly

Phase 4

Conditions: Acromegaly

Interventions: Drug: Pasireotide LAR 60 mg
Drug: Pegvisomant

First Posted Date: 2016-01-29

Last Posted Date: 2016-08-03

Lead Sponsor: Erasmus Medical Center

Target Recruit Count: 60

Registration Number: NCT02668172

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, South Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy